Join our journey
A Norwegian life-science company solving one of the largest medical challenges we are facing.
20 minutes delay

Lifecare as an investment

Lifecare’s purpose is to develop and license technology for medical use, including facilitating the production and sale of medical devices. Today people with diabetes are dependent on a painful and more than 40-year-old technology. Lifecare’s solutions have the potential to revolutionise the field of continuous glucose measurement for more the more than 530 million people living with diabetes.

 

Top 10 shareholders

Updated June 4, 2024
Name
Holdings
Share
Citizen
Teigland Eiendom AS
24 691 829
18.31 %
NOR
Lacal AS
21 387 712
15.86 %
NOR
VPF Nordea Avkastning
8 393 413
6.22 %
NOR
Tjelta AS
7 670 000
5.69 %
NOR
Spit Air AS
3 087 735
2.29 %
NOR
Lt Finans As
2 500 000
1.85 %
NOR
Even Harald Einarsen
2 000 000
1.48 %
NOR
BNP Paribas
1 812 600
1.34 %
CHE
Deutsche Bank Aktiengesellschaft
1 800 229
1.33 %
GER
Nexus Marketing
1 724 221
1.28 %
NOR
Swipe for more data

Contact

Investor relations